Pharmacological interventions in experimental myocardial infarction.
作者信息
Cooper E G, Booker W M, Johnson J B
出版信息
Recent Adv Stud Cardiac Struct Metab. 1973;3:831-8.
PMID:4806683
Abstract
摘要
相似文献
1
Pharmacological interventions in experimental myocardial infarction.
Recent Adv Stud Cardiac Struct Metab. 1973;3:831-8.
2
Biochemical changes in non-infarcted heart muscle following myocardial infarction.心肌梗死后非梗死心肌的生化变化。
Recent Adv Stud Cardiac Struct Metab. 1973;2:581-9.
3
Modification of experimental myocardial infarct size by cardiac drugs.
Am J Cardiol. 1974 Apr;33(4):521-8. doi: 10.1016/0002-9149(74)90612-2.
4
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.重组胰高血糖素样肽-1可增加起搏诱导的扩张型心肌病清醒犬的心肌葡萄糖摄取并改善左心室功能。
Circulation. 2004 Aug 24;110(8):955-61. doi: 10.1161/01.CIR.0000139339.85840.DD. Epub 2004 Aug 16.
5
6
Effects of experimental coronary ligation of pH and lactate concentration in cardiac lymph.
Life Sci. 1976 Apr 1;18(7):745-9. doi: 10.1016/0024-3205(76)90186-7.
7
Increase of coronary flow and levels of PGE1 and PGF2 alpha from the ischemic area of experimental myocardial infarction.
Adv Prostaglandin Thromboxane Res. 1980;7:665-9.
8
[Protective effect of GIK-P on the ischemic myocardium].
Kokyu To Junkan. 1984 Jun;32(6):613-7.
9
[Endocrino-metabolic aspects of acute myocardial infarct].
Minerva Dietol Gastroenterol. 1981 Jul-Sep;27(3):453-66.
10
[Hemodynamic effects of glucagon in acute myocardial infarct, total A-V block and mitral stenosis].
Med Interna (Bucur). 1971 May;23(5):573-82.
Zotero 插件